The investigators will investigate the clinicopathological features of chronic hepatitis B patients with severe exacerbation selected by uniform criteria, and treated with early introduction or reintroduction of corticosteroids and anti-allergenic therapy, in order to clarify the benefits and limitations of the effects of corticosteroids and anti-allergenic therapy for amelioration of clinically severe exacerbation of chronic hepatitis B. The investigators also observe the immune index in the change before and after the treatment, in order to searching for some prognostic index.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
120
methylprednisolone 1mg/kg intravenous drip qd,for 3 days glucocorticoid
Deparment of Infectious Diseases, the Second Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
RECRUITINGsurvival rate
Time frame: eight weeks
liver function
ALT,albumin,bilirubine,
Time frame: eight weeks
HBV-DNA
Time frame: eight weeks
prothrombin activity
Time frame: eight weeks
Child-Pugh degree
Time frame: eight weeks
model for end-stage liver disease
Time frame: eight weeks
length of patient stay
Time frame: eight weeks
hospitalization costs
Time frame: eight weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.